Association of monocyte chemoattractant protein-1 -2518A>G polymorphism with occurrence, severity, and outcome in ischemic stroke

Neurological Sciences

Volumn 34, Issue 8, 2013, Pages 1315-1320

  Giannakopoulou, Efstathia ^a   Ragia, Georgia ^a   Marousi, Stella ^b   Ellul, John ^b   Manolopoulos, Vangelis G ^a   Tavridou, Anna ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Genetics; Ischemic stroke; Monocyte chemoattractant protein 1; Polymorphism

Indexed keywords

GENOMIC DNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENE ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MCP 1 GENE; OUTCOME ASSESSMENT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; BRAIN ISCHEMIA; CHEMOKINE CCL2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GREECE; HUMANS; MALE; POLYMORPHISM, GENETIC; STROKE;

EID: 84883170303     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-1235-2     Document Type: Article

References (32)

1. Flynn RW, MacWalter RS, Doney AS (2008) The cost of cerebral ischaemia. Neuropharmacology 55(3):250-256
2. Muir KW, Tyrrell P, Sattar N, Warburton E (2007) Inflammation and ischaemic stroke. Curr Opin Neurol 20(3):334-342
3. Tuttolomondo A, di Raimondo D, di Sciacca R, Pinto A, Licata G (2008) Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des 14(33):3574-3589
4. Mirabelli-Badenier M, Braunersreuther V, Viviani GL, Dallegri F, Quercioli A, Veneselli E, Mach F, Montecucco F (2011) CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. Thromb Haemost 105(3):409-420
5. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D (1991) Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88(12):5252-5256
6. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM (1990) Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87(13):5134-5138
7. Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394(6696):894-897
8. Wang X, Yue TL, Barone FC, Feuerstein GZ (1995) Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 26(4):661-666
9. Yamagami S, Tamura M, Hayashi M, Endo N, Tanabe H, Katsuura Y, Komoriya K (1999) Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats. J Leukoc Biol 65(6):744-749
10. Arakelyan A, Petrkova J, Hermanova Z, Boyajyan A, Lukl J, Petrek M (2005) Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediat Inflamm 3:175-179
11. Losy J, Zaremba J (2001) Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 32(11):2695-2696
12. Hu ZJ, Liao Y, Hu LY, Wang JL, Li J, Lu WM, Wang SM (2009) Effects of antiatherosclerosis in carotid artery by RNAi-mediated silencing of MCP-1 expression. Ann Vasc Surg 23(5):652-662
13. Schilling M, Strecker JK, Schabitz WR, Ringelstein EB, Kiefer R (2009) Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 161(3):806-812
14. Kim HL, Lee DS, Yang SH, Lim CS, Chung JH, Kim S, Lee JS, Kim YS (2002) The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 40(6):1146-1152
15. Simeoni E, Hoffmann MM, Winkelmann BR, Ruiz J, Fleury S, Boehm BO, Marz W, Vassalli G (2004) Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and type 2 diabetes mellitus. Diabetologia 47(9):1574-1580
16. Rovin BH, Lu L, Saxena R (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259(2):344-348
17. Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B, Horvath L, Csaszar A (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158(1):233-239
18. Fenoglio C, Galimberti D, Lovati C, Guidi I, Gatti A, Fogliarino S, Tiriticco M, Mariani C, Forloni G, Pettenati C, Baron P, Conti G, Bresolin N, Scarpini E (2004) MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging 25(9):1169-1173
19. Tabara Y, Kohara K, Yamamoto Y, Igase M, Nakura J, Kondo I, Miki T (2003) Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 26(9):677-683
20. McDermott DH, Yang Q, Kathiresan S, Cupples LA, Massaro JM, Keaney JF Jr, Larson MG, Vasan RS, Hirschhorn JN, O'Donnell CJ, Murphy PM, Benjamin EJ (2005) CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 112(8):1113-1120
21. Yuasa S, Maruyama T, Yamamoto Y, Hirose H, Kawai T, Matsunaga-Irie S, Itoh H (2009) MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes. Diabetes Res Clin Pract 86(3):193-198
22. Jemaa R, Ben Ali S, Kallel A, Omar S, Feki M, Elasmi M, Haj-Taieb S, Sanhaji H, Kaabachi N (2009) Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and hypertension in Tunisian patients. Clin Biochem 42(1-2):34-37
23. Wang Y, Zhang W, Li S, Song W, Chen J, Hui R (2011) Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: a meta-analysis. Atherosclerosis 219(1):224-230
24. Bamford JM, Sandercock PA, Warlow CP, Slattery J (1989) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 20(6):828
25. Scandinavian Stroke Study Group (1988) Multicenter trial of hemodilution in acute ischemic stroke. Results of subgroup analyses. Stroke 19(4):464-471
26. Gioldasis G, Talelli P, Chroni E, Daouli J, Papapetropoulos T, Ellul J (2008) In-hospital direct cost of acute ischemic and hemorrhagic stroke in Greece. Acta Neurol Scand 118(4):268-274
27. Marousi S, Ellul J, Antonacopoulou A, Gogos C, Papathanasopoulos P, Karakantza M (2011) Functional polymorphisms of interleukin 4 and interleukin 10 may predict evolution and functional outcome of an ischaemic stroke. Eur J Neurol 18(4):637-643
28. Bjarnadottir K, Eiriksdottir G, Aspelund T, Gudnason V (2006) Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population. Atherosclerosis 188(2):341-346
29. Pola R, Flex A, Gaetani E, Proia AS, Papaleo P, Di Giorgio A, Straface G, Pecorini G, Serricchio M, Pola P (2004) Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians. Exp Gerontol 39(8):1249-1252
30. Brenner D, Labreuche J, Touboul PJ, Schmidt-Petersen K, Poirier O, Perret C, Schonfelder J, Combadiere C, Lathrop M, Cambien F, Brand-Herrmann SM, Amarenco P (2006) Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients. Stroke 37(7):1691-1696
31. Flex A, Gaetani E, Papaleo P, Straface G, Proia AS, Pecorini G, Tondi P, Pola P, Pola R (2004) Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 35(10):2270-2275
32. Buraczynska K, Luchowski P, Wojczal J, Ksiazek A, Stelmasiak Z (2010) Monocyte chemoattractant protein (MCP-1) A-2518G gene polymorphism in stroke patients with different comorbidities. Clin Biochem 43(18):1421-1426